CA Stock MarketDetailed Quotes
XRX XORTX Therapeutics Inc
- 4.800
- 0.0000.00%
15min DelayMarket Closed Nov 4 16:00 ET
59.00MMarket Cap-13636P/E (TTM)
0.000High0.000Low0Volume0.000Open4.800Pre Close0.00Turnover5.15052wk High0.00%Turnover Ratio12.29MShares3.18052wk Low-0.352EPS TTM52.74MFloat Cap9.979Historical HighLossP/E (Static)10.99MShs Float0.352Historical Low-0.235EPS LYR0.00%Amplitude--Dividend TTM17.78P/B1Lot Size--Div YieldTTM
XORTX Therapeutics Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | (FY)Dec 31, 2019 | (Q4)Dec 31, 2019 | (Q3)Sep 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 133.34%865.45K | 360.17%770.45K | 129.79%1.3M | 130.68%380.34K | 186.72%381.84K | 164.45%370.89K | 0.00%167.43K | -51.09%565.97K | 20.71%164.88K | -54.70%133.18K |
| Selling and administrative expenses | 136.21%834.65K | 370.40%752.42K | 116.94%1.1M | 107.24%328.14K | 110.83%256.65K | 194.32%353.35K | 0.00%159.96K | -36.38%506.17K | 42.01%158.34K | -19.48%121.74K |
| -General and administrative expense | 136.21%834.65K | 370.40%752.42K | 116.94%1.1M | 107.24%328.14K | 110.83%256.65K | 194.32%353.35K | 0.00%159.96K | -36.38%506.17K | 42.01%158.34K | -19.48%121.74K |
| Research and development costs | 112.20%26.42K | 469.20%13.79K | 595.43%277.46K | 9,204.70%142.55K | 1,765.60%120.03K | -18.27%12.45K | 0.00%2.42K | -88.34%39.9K | -92.41%1.53K | -95.34%6.43K |
| Depreciation amortization depletion | -14.17%4.37K | -15.96%4.24K | 2.71%20.44K | 2.62%5.14K | 2.92%5.15K | 2.70%5.1K | 0.00%5.05K | 3.02%19.9K | 1.77%5.01K | 2.77%5.01K |
| -Depreciation and amortization | -14.17%4.37K | -15.96%4.24K | 2.71%20.44K | 2.62%5.14K | 2.92%5.15K | 2.70%5.1K | 0.00%5.05K | 3.02%19.9K | 1.77%5.01K | 2.77%5.01K |
| Other operating expenses | ---- | ---- | ---95.49K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | -133.34%-865.45K | -360.17%-770.45K | -129.79%-1.3M | -130.68%-380.34K | -186.72%-381.84K | -164.45%-370.89K | 0.00%-167.43K | 51.09%-565.97K | -20.71%-164.88K | 54.70%-133.18K |
| Net non-operating interest income (expenses) | 77.46%-665 | 78.87%-1.88K | 63.69%-13.51K | 94.36%-815 | 84.00%-839 | 69.01%-2.95K | 0.00%-8.91K | -66.89%-37.21K | -95.08%-14.46K | -43.35%-5.25K |
| Non-operating interest expense | -77.46%665 | -78.87%1.88K | -63.69%13.51K | -94.36%815 | -84.00%839 | -69.01%2.95K | 0.00%8.91K | 66.89%37.21K | 95.08%14.46K | 43.35%5.25K |
| Other net income (expenses) | 605,193.46%647.66K | -1,079.09%-1.4M | 211.43%29.41K | -606.77%-71.57K | -742.87%-42.23K | 101.89%107 | 0.00%143.1K | 98.98%-26.4K | -193.34%-10.13K | 171.46%6.57K |
| Gain on sale of security | 812.45%647.66K | -1,019.18%-1.32M | 111.22%2.96K | 30.81%-7.01K | -742.87%-42.23K | -1,508.69%-90.91K | 0.00%143.1K | -162.29%-26.4K | -137.43%-10.13K | 171.46%6.57K |
| Special income (charges) | --0 | ---- | --26.45K | ---64.56K | --0 | --91.01K | ---- | --0 | --0 | --0 |
| -Less:Impairment of capital assets | ---- | ---- | --64.56K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---91.01K | --0 | ---- | ---91.01K | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | ---- | ---85.73K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 41.55%-218.45K | -6,440.44%-2.17M | -104.04%-1.28M | -138.95%-452.73K | -222.26%-424.91K | -140.47%-373.74K | 0.00%-33.23K | 83.33%-629.58K | -28.48%-189.47K | 57.03%-131.85K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 41.55%-218.45K | -6,440.44%-2.17M | -104.04%-1.28M | -138.95%-452.73K | -222.26%-424.91K | -140.47%-373.74K | 0.00%-33.23K | 83.33%-629.58K | -28.48%-189.47K | 57.03%-131.85K |
| Net income continuous operations | 41.55%-218.45K | -6,440.44%-2.17M | -104.04%-1.28M | -138.95%-452.73K | -222.26%-424.91K | -140.47%-373.74K | 0.00%-33.23K | 83.33%-629.58K | -28.48%-189.47K | 57.03%-131.85K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 41.55%-218.45K | -6,440.44%-2.17M | -104.04%-1.28M | -138.95%-452.73K | -222.26%-424.91K | -140.47%-373.74K | 0.00%-33.23K | 83.33%-629.58K | -28.48%-189.47K | 57.03%-131.85K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 41.55%-218.45K | -6,440.44%-2.17M | -104.04%-1.28M | -138.95%-452.73K | -222.26%-424.91K | -140.47%-373.74K | 0.00%-33.23K | 83.33%-629.58K | -28.48%-189.47K | 57.03%-131.85K |
| Diluted earnings per share | 80.16%-0.0233 | -4,073.48%-0.2348 | -100.00%-0.2348 | -0.1174 | -377.20%-0.1174 | -304.84%-0.1174 | 0.00%-0.0056 | 83.33%-0.1174 | 0 | 57.03%-0.0246 |
| Basic earnings per share | 80.16%-0.0233 | -4,073.48%-0.2348 | -100.00%-0.2348 | -0.1174 | -377.20%-0.1174 | -304.84%-0.1174 | 0.00%-0.0056 | 83.33%-0.1174 | 0 | 57.03%-0.0246 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg